Matrix Capital Management Company’s Adaptive Biotechnologies ADPT Stock Holding History

Matrix Capital Management Company’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-650,000	Closed	-$3.33M	–	7
2024 Q3	$3.33M	Sell	650,000 -10,922,590	-94%	-$47.6M	0.16%	7
2024 Q2	$41.9M	Hold	11,572,590	–	–	0.32%	19
2024 Q1	$37.1M	Hold	11,572,590	–	–	0.35%	20
2023 Q4	$56.7M	Hold	11,572,590	–	–	0.58%	14
2023 Q3	$63.1M	Hold	11,572,590	–	–	0.76%	14
2023 Q2	$77.7M	Hold	11,572,590	–	–	0.9%	13
2023 Q1	$102M	Hold	11,572,590	–	–	1.39%	12
2022 Q4	$88.4M	Hold	11,572,590	–	–	1.69%	11
2022 Q3	$82.4M	Hold	11,572,590	–	–	1.58%	14
2022 Q2	$93.6M	Hold	11,572,590	–	–	2.12%	12
2022 Q1	$161M	Hold	11,572,590	–	–	1.93%	17
2021 Q4	$325M	Hold	11,572,590	–	–	3.62%	14
2021 Q3	$393M	Sell	11,572,590 -227,500	-2%	-$8.23M	4.48%	9
2021 Q2	$482M	Sell	11,800,090 -509,000	-4%	-$19.8M	5.27%	7
2021 Q1	$496M	Sell	12,309,090 -806,000	-6%	-$43.6M	5.72%	7
2020 Q4	$775M	Hold	13,115,090	–	–	8.39%	2
2020 Q3	$638M	Sell	13,115,090 -2,000,000	-13%	-$84.1M	8.48%	3
2020 Q2	$731M	Hold	15,115,090	–	–	11.4%	2
2020 Q1	$420M	Sell	15,115,090 -2,217,101	-13%	-$61.8M	10.73%	2
2019 Q4	$519M	Hold	17,332,191	–	–	11.04%	3
2019 Q3	$536M	Hold	17,332,191	–	–	13.21%	2
2019 Q2	$837M	Buy	+17,332,191	New	+$768M	15.47%	1

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Matrix Capital Management Company's ADPT Position: Q4 2024 in Review

Matrix Capital Management Company sold out of Adaptive Biotechnologies (ADPT) in Q4 2024, closing a stake of 650,000 shares — an estimated $3.33M sold.

Matrix Capital Management Company first reported a position in ADPT in Q2 2019 and held it in 22 quarters. The position peaked at $837M in Q2 2019. 207 funds tracked by Wall St. Rank hold ADPT as of Q4 2024.

Matrix Capital Management Company reported no remaining Adaptive Biotechnologies position as of Q4 2024 after selling out during the quarter.
Matrix Capital Management Company sold 650,000 Adaptive Biotechnologies shares in Q4 2024, an estimated $3.33M.
Matrix Capital Management Company first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 22 quarters.
Matrix Capital Management Company's Adaptive Biotechnologies position peaked at $837M in Q2 2019.
207 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2024.

Based on Matrix Capital Management Company's 13F filing for Q4 2024, filed 13 Feb 2025.